Latest News and Press Releases
Want to stay updated on the latest news?
-
Greeley, Colorado, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited plant-based extractor and finished product manufacturer, is proud to...
-
洛杉磯, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail， Inc.（納斯達克股票代碼：SNAL）（以下簡稱 “蝸牛”或“公司”）是一家全球領先的互動數位娛樂獨立開發商和發行商。 蝸牛與驢子幫工作室（Donkey Crew）在TGA遊戲大獎中展示了即將推出的遊戲《貝爾萊特 Bellwright》的全新預告片。 TGA 遊戲大獎一直致力於展示尖端的遊戲體驗。...
-
洛杉矶, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail, Inc.（纳斯达克股票代码：SNAL）（以下简称 “蜗牛”或“公司”）是一家全球领先的互动数字娱乐独立开发商和发行商。蜗牛与驴子帮工作室（Donkey Crew）在TGA游戏大奖中展示了即将推出的游戏《贝尔莱特 Bellwright》的全新预告片。 TGA...
-
LOS ANGELES, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, in...
-
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
-
Greeley, Colorado, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods...
-
Highlights: Incannex subsidiary, Clarion Clinics Group Pty Ltd (Clarion) begins accepting registrations of interest in its psychedelic-assisted therapy (PAT) treatments ahead of planned Q3...
-
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
-
Highlights: Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-traumatic stress disorder (PTSD) have access to medical grade GMP MDMA (using...
-
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...